TapewireFind a company

person · Reporting owner

STEFANOVICH ROBERT

Disclosed activity across 1 company

Tapewire entity
40622
SEC CIK
0001247309

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Cryoport, Inc.CYRX · Entity 5125Chief Financial OfficerJune 04, 2026June 09, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Cryoport, Inc.

Report date June 04, 2026 · Filed June 09, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect109,850 Reported balance After 2026-06-04 transaction · row 1
1 source row

Row 1 · 2026-06-04 · Sale · Disposed 169,427 · Balance 109,850

F1: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.05 to $16.70, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Filing footnotes · ownership attribution and instrument terms

F1: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.05 to $16.70, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
June 04, 2026 Filed Jun 9, 2026 01:11 UTC Cryoport, Inc. CYRX · Entity 5125 SaleCommon Stock 169,427 $16.27 $2,756,983.91
Disclosure

SEC source: 0001104659-26-071509 · tm2617191-5_4seq1.xml · nonDerivative · entry 1

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 109,850

F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.05 to $16.70, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 23, 2026 Filed Mar 26, 2026 00:01 UTC Cryoport, Inc. CYRX · Entity 5125 SaleCommon Stock 1,094 $8.18 $8,948.92
Disclosure

SEC source: 0001104659-26-034754 · tm269766-3_4seq1.xml · nonDerivative · entry 1

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 279,277

F1 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.

Read SEC document
March 16, 2026 Filed Mar 17, 2026 01:35 UTC Cryoport, Inc. CYRX · Entity 5125 SaleCommon Stock 2,743 $8.00 $21,944.00
Disclosure

SEC source: 0001104659-26-028775 · tm269014-1_4seq1.xml · nonDerivative · entry 4

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 280,371

F4 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.

Read SEC document
March 14, 2026 Filed Mar 17, 2026 01:35 UTC Cryoport, Inc. CYRX · Entity 5125 GrantStock Option (right to buy) · Derivative 82,240 $0.00 Strike: $8.60 $0.00
Disclosure

SEC source: 0001104659-26-028775 · tm269014-1_4seq1.xml · derivative · entry 6

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,240

Underlying: Common Stock · 82,240 shares

Expires 2033-03-14

F6 · derivative.exercise_date: 1/48 of options vest on the 14th of each month for forty-eight months beginning April 14, 2026.

Read SEC document
March 14, 2026 Filed Mar 17, 2026 01:35 UTC Cryoport, Inc. CYRX · Entity 5125 GrantCommon Stock 27,413 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-028775 · tm269014-1_4seq1.xml · nonDerivative · entry 3

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 283,114

F3 · security: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 14, 2027.

F3 · price: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 14, 2027.

Read SEC document
March 12, 2026 Filed Mar 17, 2026 01:35 UTC Cryoport, Inc. CYRX · Entity 5125 Exercise / conversionOptions to purchase common stock · Derivative 87,188 $0.00 Strike: $1.87 $0.00
Disclosure

SEC source: 0001104659-26-028775 · tm269014-1_4seq1.xml · derivative · entry 5

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 87,188 shares

Expires 2026-05-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: 1/48 of options vested on the 6th of each month for forty-eight months beginning May 6, 2016.

Read SEC document
March 12, 2026 Filed Mar 17, 2026 01:35 UTC Cryoport, Inc. CYRX · Entity 5125 SaleCommon Stock 38,700 $7.76 $300,385.53
Disclosure

SEC source: 0001104659-26-028775 · tm269014-1_4seq1.xml · nonDerivative · entry 2

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 255,701

F1 · kind: The proceeds of the sale of Common Stock were used to pay the exercise price and withholding taxes due upon exercise of the Stock Option reported in this Form 4.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.725 to $7.83, inclusive.

Read SEC document
March 12, 2026 Filed Mar 17, 2026 01:35 UTC Cryoport, Inc. CYRX · Entity 5125 Exercise / conversionCommon Stock 87,188 $1.87 $163,041.56
Disclosure

SEC source: 0001104659-26-028775 · tm269014-1_4seq1.xml · nonDerivative · entry 1

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 294,401

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 19, 2025 Filed Aug 21, 2025 21:00 UTC Cryoport, Inc. CYRX · Entity 5125 Exercise / conversionOptions to purchase common stock · Derivative 26,164 $0.00 Strike: $3.07 $0.00
Disclosure

SEC source: 0001104659-25-081460 · tm2524098-1_4seq1.xml · derivative · entry 3

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 26,164 shares

Expires 2025-08-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 1/48 of the options vested on the 20th of each month for forty-eight months beginning on August 19, 2015.

Read SEC document
August 19, 2025 Filed Aug 21, 2025 21:00 UTC Cryoport, Inc. CYRX · Entity 5125 SaleCommon Stock 9,300 $8.67 $80,617.98
Disclosure

SEC source: 0001104659-25-081460 · tm2524098-1_4seq1.xml · nonDerivative · entry 2

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 207,213

F1 · kind: The proceeds of the sale of Common Stock were used to pay the exercise price due upon the exercise of the Stock Option reported in this Form 4.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.60 to $8.75, inclusive.

Read SEC document
August 19, 2025 Filed Aug 21, 2025 21:00 UTC Cryoport, Inc. CYRX · Entity 5125 Exercise / conversionCommon Stock 26,164 $3.07 $80,323.48
Disclosure

SEC source: 0001104659-25-081460 · tm2524098-1_4seq1.xml · nonDerivative · entry 1

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 216,513

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 24, 2025 Filed Mar 26, 2025 23:00 UTC Cryoport, Inc. CYRX · Entity 5125 SaleCommon Stock 1,070 $6.94 $7,427.51
Disclosure

SEC source: 0001104659-25-028322 · tm2510559-2_4seq1.xml · nonDerivative · entry 1

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 190,349

F1 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.

Read SEC document
March 17, 2025 Filed Mar 18, 2025 23:07 UTC Cryoport, Inc. CYRX · Entity 5125 SaleCommon Stock 1,659 $6.29 $10,437.93
Disclosure

SEC source: 0001104659-25-025194 · tm259699-3_4seq1.xml · nonDerivative · entry 2

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 191,419

F2 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.

Read SEC document
March 14, 2025 Filed Mar 18, 2025 23:07 UTC Cryoport, Inc. CYRX · Entity 5125 GrantStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $7.05 $0.00
Disclosure

SEC source: 0001104659-25-025194 · tm259699-3_4seq1.xml · derivative · entry 3

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2032-03-14

F3 · derivative.exercise_date: 1/48 of options vest on the 14th of each month for forty-eight months beginning April 14, 2025.

Read SEC document
March 14, 2025 Filed Mar 18, 2025 23:07 UTC Cryoport, Inc. CYRX · Entity 5125 GrantCommon Stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-025194 · tm259699-3_4seq1.xml · nonDerivative · entry 1

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 193,078

F1 · security: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 14, 2026.

F1 · price: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 14, 2026.

Read SEC document
March 10, 2025 Filed Mar 11, 2025 23:00 UTC Cryoport, Inc. CYRX · Entity 5125 SaleCommon Stock 1,256 $4.88 $6,128.15
Disclosure

SEC source: 0001104659-25-022642 · tm258882-1_4seq1.xml · nonDerivative · entry 2

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 183,078

F2 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.

Read SEC document
March 09, 2025 Filed Mar 11, 2025 23:00 UTC Cryoport, Inc. CYRX · Entity 5125 Exercise / conversionRestricted Stock Rights · Derivative 2,667 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-022642 · tm258882-1_4seq1.xml · derivative · entry 3

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,667 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The originally granted restricted stock rights vest in four equal annual installments beginning March 9, 2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2025.

F1 · kind: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.

F3 · derivative.exercise_date: The originally granted restricted stock rights vest in four equal annual installments beginning March 9, 2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2025.

F3 · derivative.expiration_date: The originally granted restricted stock rights vest in four equal annual installments beginning March 9, 2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2025.

Read SEC document
March 09, 2025 Filed Mar 11, 2025 23:00 UTC Cryoport, Inc. CYRX · Entity 5125 Exercise / conversionCommon Stock 2,667 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-022642 · tm258882-1_4seq1.xml · nonDerivative · entry 1

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 184,334

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.

F1 · price: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.

Read SEC document
December 11, 2024 Filed Dec 13, 2024 23:13 UTC Cryoport, Inc. CYRX · Entity 5125 Exercise / conversionOptions to purchase common stock · Derivative 53,334 $0.00 Strike: $4.80 $0.00
Disclosure

SEC source: 0001104659-24-128537 · tm2431099-1_4seq1.xml · derivative · entry 2

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 53,334 shares

Expires 2024-12-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The options vested ratably beginning on the 18th of each month for forty-eight months beginning on 1/18/2015.

Read SEC document
December 11, 2024 Filed Dec 13, 2024 23:13 UTC Cryoport, Inc. CYRX · Entity 5125 Exercise / conversionCommon Stock 53,334 $4.80 $256,003.20
Disclosure

SEC source: 0001104659-24-128537 · tm2431099-1_4seq1.xml · nonDerivative · entry 1

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 181,667

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 25, 2024 Filed Mar 27, 2024 00:12 UTC Cryoport, Inc. CYRX · Entity 5125 SaleCommon Stock 1,079 $17.54 $18,928.14
Disclosure

SEC source: 0001104659-24-039195 · tm249900-3_4seq1.xml · nonDerivative · entry 1

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 128,333

F1 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.

Read SEC document
March 15, 2024 Filed Mar 19, 2024 23:51 UTC Cryoport, Inc. CYRX · Entity 5125 GrantStock Option (right to buy) · Derivative 11,500 $0.00 Strike: $16.70 $0.00
Disclosure

SEC source: 0001104659-24-036286 · tm249281-5_4seq1.xml · derivative · entry 6

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,500

Underlying: Common Stock · 11,500 shares

Expires 2031-03-15

F5 · derivative.exercise_date: 1/48 of options vest on the 15th of each month for forty-eight months beginning April 25, 2024.

Read SEC document
March 15, 2024 Filed Mar 19, 2024 23:51 UTC Cryoport, Inc. CYRX · Entity 5125 GrantCommon Stock 5,750 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-036286 · tm249281-5_4seq1.xml · nonDerivative · entry 4

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 129,412

F3 · security: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 15, 2025.

F3 · price: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 15, 2025.

Read SEC document
March 15, 2024 Filed Mar 19, 2024 23:51 UTC Cryoport, Inc. CYRX · Entity 5125 SaleCommon Stock 1,035 $15.43 $15,972.33
Disclosure

SEC source: 0001104659-24-036286 · tm249281-5_4seq1.xml · nonDerivative · entry 3

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 123,662

F2 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.

Read SEC document
March 11, 2024 Filed Mar 19, 2024 23:51 UTC Cryoport, Inc. CYRX · Entity 5125 SaleCommon Stock 1,119 $16.35 $18,298.34
Disclosure

SEC source: 0001104659-24-036286 · tm249281-5_4seq1.xml · nonDerivative · entry 2

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 124,697

F2 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.

Read SEC document
March 09, 2024 Filed Mar 19, 2024 23:51 UTC Cryoport, Inc. CYRX · Entity 5125 Exercise / conversionRestricted Stock Rights · Derivative 2,666 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-036286 · tm249281-5_4seq1.xml · derivative · entry 5

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,667

Underlying: Common Stock · 2,666 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: The originally granted restricted stock rights vest in four equal annual installments beginning March 9, 2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2024.

F1 · kind: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.

F4 · derivative.exercise_date: The originally granted restricted stock rights vest in four equal annual installments beginning March 9, 2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2024.

F4 · derivative.expiration_date: The originally granted restricted stock rights vest in four equal annual installments beginning March 9, 2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2024.

Read SEC document
March 09, 2024 Filed Mar 19, 2024 23:51 UTC Cryoport, Inc. CYRX · Entity 5125 Exercise / conversionCommon Stock 2,666 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-036286 · tm249281-5_4seq1.xml · nonDerivative · entry 1

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,816

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.

F1 · price: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.

Read SEC document
August 29, 2023 Filed Aug 30, 2023 21:30 UTC Cryoport, Inc. CYRX · Entity 5125 Exercise / conversionOptions to purchase common stock · Derivative 16,000 $0.00 Strike: $3.07 $0.00
Disclosure

SEC source: 0001104659-23-096929 · tm2325164-1_4.xml · derivative · entry 2

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,164

Underlying: Common Stock · 16,000 shares

Expires 2025-08-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 1/48 of the options vested on the 20th of each month for forty-eight months beginning on August 19, 2015.

Read SEC document
August 29, 2023 Filed Aug 30, 2023 21:30 UTC Cryoport, Inc. CYRX · Entity 5125 Exercise / conversionCommon Stock 16,000 $3.07 $49,120.00
Disclosure

SEC source: 0001104659-23-096929 · tm2325164-1_4.xml · nonDerivative · entry 1

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 123,150

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: No Common Stock was sold by the reporting person in connection with the transactions disclosed on this Form 4.

Read SEC document
May 10, 2023 Filed May 12, 2023 22:21 UTC Cryoport, Inc. CYRX · Entity 5125 Exercise / conversionOptions to purchase common stock · Derivative 19,918 $0.00 Strike: $3.24 $0.00
Disclosure

SEC source: 0001104659-23-059931 · tm2315733-1_4seq1.xml · derivative · entry 3

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 19,918 shares

Expires 2023-06-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Options vested over four years in 48 equal installments beginning 7/28/2013.

Read SEC document
May 10, 2023 Filed May 12, 2023 22:21 UTC Cryoport, Inc. CYRX · Entity 5125 SaleCommon Stock 19,918 $21.94 $437,022.83
Disclosure

SEC source: 0001104659-23-059931 · tm2315733-1_4seq1.xml · nonDerivative · entry 2

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 107,150

F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.575 to $22.27, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 10, 2023 Filed May 12, 2023 22:21 UTC Cryoport, Inc. CYRX · Entity 5125 Exercise / conversionCommon Stock 19,918 $3.24 $64,534.32
Disclosure

SEC source: 0001104659-23-059931 · tm2315733-1_4seq1.xml · nonDerivative · entry 1

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 127,068

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 22, 2023 Filed Mar 24, 2023 22:00 UTC Cryoport, Inc. CYRX · Entity 5125 GrantStock Option (right to buy) · Derivative 20,910 $0.00 Strike: $23.78 $0.00
Disclosure

SEC source: 0001104659-23-036715 · tm2310574-3_4seq1.xml · derivative · entry 2

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,910

Underlying: Common Stock · 20,910 shares

Expires 2030-03-22

F2 · derivative.exercise_date: 1/48 of options vest on the 22nd of each month for forty-eight months beginning 4/22/2023.

Read SEC document
March 22, 2023 Filed Mar 24, 2023 22:00 UTC Cryoport, Inc. CYRX · Entity 5125 GrantCommon Stock 10,455 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-036715 · tm2310574-3_4seq1.xml · nonDerivative · entry 1

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,150

F1 · security: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning 3/22/2024.

F1 · price: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning 3/22/2024.

Read SEC document
March 15, 2023 Filed Mar 17, 2023 20:15 UTC Cryoport, Inc. CYRX · Entity 5125 SaleCommon Stock 1,069 $20.79 $22,224.51
Disclosure

SEC source: 0001104659-23-033868 · tm239899-1_4seq1.xml · nonDerivative · entry 1

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,695

F1 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.

Read SEC document
March 13, 2023 Filed Mar 14, 2023 01:25 UTC Cryoport, Inc. CYRX · Entity 5125 SaleCommon Stock 1,159 $20.14 $23,342.26
Disclosure

SEC source: 0001104659-23-031941 · tm239488d3_4.xml · nonDerivative · entry 2

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 97,764

F2 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.

Read SEC document
March 09, 2023 Filed Mar 14, 2023 01:25 UTC Cryoport, Inc. CYRX · Entity 5125 Exercise / conversionRestricted Stock Rights · Derivative 2,667 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-031941 · tm239488d3_4.xml · derivative · entry 3

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,333

Underlying: Common Stock · 2,667 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The originally granted restricted stock rights vest in four equal annual installments beginning 3/9/2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2023.

F1 · kind: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.

F3 · derivative.exercise_date: The originally granted restricted stock rights vest in four equal annual installments beginning 3/9/2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2023.

F3 · derivative.expiration_date: The originally granted restricted stock rights vest in four equal annual installments beginning 3/9/2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2023.

Read SEC document
March 09, 2023 Filed Mar 14, 2023 01:25 UTC Cryoport, Inc. CYRX · Entity 5125 Exercise / conversionCommon Stock 2,667 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-031941 · tm239488d3_4.xml · nonDerivative · entry 1

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,923

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.

F1 · price: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.

Read SEC document
March 14, 2022 Filed Mar 16, 2022 23:00 UTC Cryoport, Inc. CYRX · Entity 5125 GrantStock Option (right to buy) · Derivative 20,910 $0.00 Strike: $29.69 $0.00
Disclosure

SEC source: 0001104659-22-034627 · tm229493-2_4seq1.xml · derivative · entry 2

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,910

Underlying: Common Stock · 20,910 shares

Expires 2029-03-14

F2 · derivative.exercise_date: 1/48 of options vest on the 14th of each month for forty-eight months beginning 4/14/2022.

Read SEC document
March 14, 2022 Filed Mar 16, 2022 23:00 UTC Cryoport, Inc. CYRX · Entity 5125 GrantCommon Stock 10,455 $0.00 $0.00
Disclosure

SEC source: 0001104659-22-034627 · tm229493-2_4seq1.xml · nonDerivative · entry 1

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,256

F1 · security: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning 3/14/2023.

F1 · price: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning 3/14/2023.

Read SEC document
March 09, 2022 Filed Mar 11, 2022 22:50 UTC Cryoport, Inc. CYRX · Entity 5125 Exercise / conversionRestricted Stock Rights · Derivative 2,667 $0.00 $0.00
Disclosure

SEC source: 0001104659-22-032999 · tm228984-3_4seq1.xml · derivative · entry 3

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,000

Underlying: Common Stock · 2,667 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The originally granted restricted stock rights vest in four equal annual installments beginning 3/9/2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2022.

F1 · kind: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.

F3 · derivative.exercise_date: The originally granted restricted stock rights vest in four equal annual installments beginning 3/9/2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2022.

F3 · derivative.expiration_date: The originally granted restricted stock rights vest in four equal annual installments beginning 3/9/2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2022.

Read SEC document
March 09, 2022 Filed Mar 11, 2022 22:50 UTC Cryoport, Inc. CYRX · Entity 5125 SaleCommon Stock 1,095 $31.05 $33,999.75
Disclosure

SEC source: 0001104659-22-032999 · tm228984-3_4seq1.xml · nonDerivative · entry 2

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,801

F2 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.

Read SEC document
March 09, 2022 Filed Mar 11, 2022 22:50 UTC Cryoport, Inc. CYRX · Entity 5125 Exercise / conversionCommon Stock 2,667 $0.00 $0.00
Disclosure

SEC source: 0001104659-22-032999 · tm228984-3_4seq1.xml · nonDerivative · entry 1

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,896

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.

F1 · price: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.

Read SEC document
January 27, 2022 Filed Feb 1, 2022 00:35 UTC Cryoport, Inc. CYRX · Entity 5125 Exercise / conversionOptions to purchase common stock · Derivative 5,000 $0.00 Strike: $5.16 $0.00
Disclosure

SEC source: 0001104659-22-009896 · tm225040-1_4seq1.xml · derivative · entry 4

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires 2022-08-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Options vested in equal installments every 6 months for 48 months.

Read SEC document
January 27, 2022 Filed Feb 1, 2022 00:35 UTC Cryoport, Inc. CYRX · Entity 5125 Exercise / conversionOptions to purchase common stock · Derivative 47,812 $0.00 Strike: $1.87 $0.00
Disclosure

SEC source: 0001104659-22-009896 · tm225040-1_4seq1.xml · derivative · entry 3

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 47,812 shares

Expires 2026-05-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: 1/48 of the options vested on the 6th of each month for forty-eight months beginning on May 6, 2016.

Read SEC document
January 27, 2022 Filed Feb 1, 2022 00:35 UTC Cryoport, Inc. CYRX · Entity 5125 Exercise / conversionCommon Stock 5,000 $5.16 $25,800.00
Disclosure

SEC source: 0001104659-22-009896 · tm225040-1_4seq1.xml · nonDerivative · entry 2

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,229

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 27, 2022 Filed Feb 1, 2022 00:35 UTC Cryoport, Inc. CYRX · Entity 5125 Exercise / conversionCommon Stock 47,812 $1.87 $89,408.44
Disclosure

SEC source: 0001104659-22-009896 · tm225040-1_4seq1.xml · nonDerivative · entry 1

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,229

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 14, 2021 Filed Oct 15, 2021 22:57 UTC Cryoport, Inc. CYRX · Entity 5125 Exercise / conversionOptions to purchase common stock · Derivative 49,918 $0.00 Strike: $7.80 $0.00
Disclosure

SEC source: 0001104659-21-126858 · tm2130186-1_4seq1.xml · derivative · entry 4

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,566

Underlying: Common Stock · 49,918 shares

Expires 2025-05-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2021.

F4 · derivative.exercise_date: Options vested on the 7th of each month for 48 months beginning on June 7, 2015.

Read SEC document
October 14, 2021 Filed Oct 15, 2021 22:57 UTC Cryoport, Inc. CYRX · Entity 5125 SaleCommon Stock 6,180 $68.38 $422,580.98
Disclosure

SEC source: 0001104659-21-126858 · tm2130186-1_4seq1.xml · nonDerivative · entry 3

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,417

F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2021.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.18 to $68.79, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
October 14, 2021 Filed Oct 15, 2021 22:57 UTC Cryoport, Inc. CYRX · Entity 5125 SaleCommon Stock 43,738 $67.60 $2,956,675.68
Disclosure

SEC source: 0001104659-21-126858 · tm2130186-1_4seq1.xml · nonDerivative · entry 2

STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,597

F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2021.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.17 to $68.15, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.